Skip to main navigation Skip to search Skip to main content

The FLOW Trial of Semaglutide for CKD in Type 2 Diabetes: Kidney, Cardiovascular, and Mortality Outcomes

Research output: Other contribution

Original languageUndefined/Unknown
StatePublished - Dec 1 2024

Publication series

NameArticles, Abstracts, and Reports

Cite this